Total Visits

Views
Long-term survivors with advanced non-squamous non-small cell lung cancer (NSNSCLC) treated with first-line (1l) chemotherapy (CT) plus bevacizumab (B) and maintenance (MTC) B32

Select a period of time:

Views

Views
July 20251
August 20251
September 20251
October 20250
November 20250
December 20251
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil1
Canada1
Singapore1
United States1
 

Top cities views

Views
Dallas1
Rio de Janeiro1
Toronto1